Evaluation the effect of Fumaria Parviflora on treatment of hemodialysis patients pruritus

Not Applicable

• Conditions: uremic pruritus.; Chronic kidney disease, stage 5

• Registration Number: IRCT2015080110410N2
• Lead Sponsor: Vice chancellor for research of Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

hemodialysis patients older than18 years old with itching more than 6 weeks; VAS score equal or more than 4; patients with hemodialysis twice or three times a week; patients should took at least a course of antipruritic treatment with no proper response.
Exclusion criteria: liver disease; respiratory disease; kt/V less than 1.2; convulsion history; any dermatologic disease that induce itching; hemolytic disease; malignancies; cholestasis; hepatitis B or C infection; presence of anemia with hemoglubin less than 10 .

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duo score. Timepoint: before and after intervention and weekly during intervention period. Method of measurement: by questionnair and calculating score.;Visual analogue scale. Timepoint: before and after intervention and weekly during intervention period. Method of measurement: visual analogue scale ruler.

Secondary Outcome Measures

Name	Time	Method
Interleukin4. Timepoint: Before and after intervention. Method of measurement: with Interleukin4 ELISA kit.;Interferon gama. Timepoint: Before and after intervention. Method of measurement: with Interferon gama ELISA Kit.;HsCRP. Timepoint: Before and after intervention. Method of measurement: with hsCRP ELISA kit.